Trials / Completed
CompletedNCT02149641
Parotid-sparing IMRT for Nasopharyngeal Cancer
Phase II Study of Parotid Sparing IMRT for Nasopharyngeal Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
In the treatment of nasopharyngeal cancers, to determine the incidence of high grade (≥G2) subjective xerostomia at 1 year.
Detailed description
The purpose of this study was to determine the feasibility in delivering induction chemotherapy and concomitant chemotherapy with IMRT in the treatment of locally advanced nasopharyngeal cancers and to determine the incidence of high grade (≥G2) subjective xerostomia at 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Intensity modulated radiotherapy with chemotherapy |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2011-04-01
- Completion
- 2012-04-01
- First posted
- 2014-05-29
- Last updated
- 2014-05-29
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02149641. Inclusion in this directory is not an endorsement.